Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study

被引：0
|
作者：
Hattori, N. [1 ]
Takeda, A. [2 ]
Takeda, S. [3 ]
Nishimura, A. [3 ]
Kitagawa, T. [3 ]
Mochizuki, H. [4 ]
Nagai, M. [5 ]
Takahashi, R. [6 ]
机构：
[1] Juntendo Univ, Dept Neurol, Fac Med, Tokyo, Japan
[2] Natl Hosp Org Sendai Nishitaga Hosp, Dept Neurol, Sendai, Miyagi, Japan
[3] Takeda Pharmaceut Co Ltd, Japan Dev Ctr, Osaka, Japan
[4] Osaka Univ, Dept Neurol, Grad Sch Med, Osaka, Japan
[5] Ehime Univ Hosp, Clin Therapeut Trial Ctr, Toon, Ehime, Japan
[6] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.662
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
634
引用
收藏
页码：231 / 232
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of adjunctive rasagiline in Japanese Parkinson's disease patients with wearing-off phenomena: A phase 2/3, randomized, double-blind, placebo-controlled, multicenter study
    Hattori, Nobutaka
    Takeda, Atsushi
    Takeda, Shinichi
    Nishimura, Akira
    Kato, Masafumi
    Mochizuki, Hideki
    Nagai, Masahiro
    Takahashi, Ryosuke
    PARKINSONISM & RELATED DISORDERS, 2018, 53 : 21 - 27
  • [2] Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
    Zhang, Zhenxin
    Wang, Jian
    Chen, Shengdi
    Liu, Chunfeng
    Zhang, Baorong
    Peng, Rong
    Sun, Shenggang
    Sun, Xiangru
    Zhao, Gang
    Qu, Qiumin
    Li, Yansheng
    Zhu, Suiqiang
    Pan, Xiaoping
    Shao, Ming
    Wang, Yanping
    TRANSLATIONAL NEURODEGENERATION, 2018, 7
  • [3] Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
    Zhenxin Zhang
    Jian Wang
    Shengdi Chen
    Chunfeng Liu
    Baorong Zhang
    Rong Peng
    Shenggang Sun
    Xiangru Sun
    Gang Zhao
    Qiumin Qu
    Yansheng Li
    Suiqiang Zhu
    Xiaoping Pan
    Ming Shao
    Yanping Wang
    Translational Neurodegeneration, 7
  • [4] Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
    Stern, MB
    Marek, KL
    Friedman, J
    Hauser, RA
    LeWitt, PA
    Tarsy, D
    Olanow, CW
    MOVEMENT DISORDERS, 2004, 19 (08) : 916 - 923
  • [5] The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
    Hanagasi, Hasmet A.
    Gurvit, Hakan
    Unsalan, Pinar
    Horozoglu, Hilal
    Tuncer, Nese
    Feyzioglu, Aynur
    Gunal, Dilek Ince
    Yener, Gorsev G.
    Cakmur, Raif
    Sahin, Huseyin A.
    Emre, Murat
    MOVEMENT DISORDERS, 2011, 26 (10) : 1851 - 1858
  • [6] The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
    Hanagasi, Hasmet A.
    MOVEMENT DISORDERS, 2015, 30 (07) : 1009 - 1009
  • [7] Efficacy and safety of Rasagiline in levodopa-treated Korean Parkinson's disease patients with motor fluctuations: Randomized, placebo-controlled, double-blind study
    Yun, Ji Young
    Jeon, Beom
    Kim, Jae Woo
    Lee, Chong
    Kim, Jong-Min
    Cho, Jin Whan
    Sohn, Young
    Lee, Jee-Young
    MOVEMENT DISORDERS, 2014, 29 : S33 - S33
  • [8] Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study
    Seino, Yutaka
    Sasaki, Takashi
    Fukatsu, Atsushi
    Ubukata, Michito
    Sakai, Soichi
    Samukawa, Yoshishige
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) : 1245 - 1255
  • [9] A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    Kondo, Tomoyoshi
    Nomoto, Masahiro
    Origasa, Hideki
    Takahashi, Ryosuke
    Yamamoto, Mitsutoshi
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 201 - 207
  • [10] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
12345